Symbols / LFMD Stock $4.70 -4.08% LifeMD, Inc.

Healthcare • Health Information Services • United States • NGM
LFMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Justin Schreiber
Exch · Country NGM · United States
Market Cap 227.30M
Enterprise Value 199.00M
Income -21.30M
Sales 193.33M
FCF (ttm) -4.16M
Book/sh 0.32
Cash/sh 0.71
Employees 347
Insider 10d —
IPO Jan 29, 2008
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 9.13
PEG —
P/S 1.18
P/B 14.87
P/C —
EV/EBITDA -13.92
EV/Sales 1.03
Quick Ratio 0.89
Current Ratio 1.04
Debt/Eq 41.05
LT Debt/Eq —
EPS (ttm) -0.44
EPS next Y 0.52
EPS Growth —
Revenue Growth -1.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-06
ROA -13.41%
ROE -238.45%
ROIC —
Gross Margin 86.81%
Oper. Margin -17.80%
Profit Margin 2.93%
Shs Outstand 48.36M
Shs Float 40.08M
Insider Own 14.47%
Instit Own 37.14%
Short Float 13.82%
Short Ratio 5.67
Short Interest 5.59M
52W High 15.84
vs 52W High -70.33%
52W Low 2.56
vs 52W Low 83.59%
Beta 1.99
Impl. Vol. 12.50%
Rel Volume 0.71
Avg Volume 1.09M
Volume 773.66K
Target (mean) $9.88
Tgt Median $10.00
Tgt Low $8.00
Tgt High $15.00
# Analysts 8
Recom None
Prev Close $4.90
Price $4.70
Change -4.08%
About

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.88
Mean price target
2. Current target
$4.70
Latest analyst target
3. DCF / Fair value
$-1.55
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.70
Low
$8.00
High
$15.00
Mean
$9.88

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-26 reit HC Wainwright & Co. Buy → Buy $10
2026-05-04 reit BTIG Buy → Buy $10
2026-03-16 up Mizuho Neutral → Outperform $8
2026-03-12 main Freedom Broker Buy → Buy $10
2026-03-11 main HC Wainwright & Co. Buy → Buy $10
2026-03-10 reit BTIG Buy → Buy $10
2025-11-24 main Freedom Broker Buy → Buy $8
2025-11-19 main HC Wainwright & Co. Buy → Buy $9
2025-11-19 main Keybanc Overweight → Overweight $8
2025-11-19 main Mizuho Neutral → Neutral $6
2025-11-18 main Lake Street Buy → Buy $8
2025-11-18 main B. Riley Securities Buy → Buy $10
2025-11-18 main BTIG Buy → Buy $10
2025-08-07 main HC Wainwright & Co. Buy → Buy $13
2025-08-06 main Lake Street Buy → Buy $14
2025-08-06 main Keybanc Overweight → Overweight $12
2025-07-14 main Keybanc Overweight → Overweight $14
2025-07-10 main Lake Street Buy → Buy $18
2025-04-30 reit HC Wainwright & Co. Buy → Buy $14
2025-03-12 main HC Wainwright & Co. Buy → Buy $14
News
RSS: Latest LFMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-01 SRIPAD UMESH Chief Technology Officer — 75,000 $0.00 $0
2026-05-11 KAVTHEKAR ATUL Chief Financial Officer — 337,500 $0.00 $0
2026-03-30 PISANO CHRISTOPHER A Officer — 200,000 $0.00 $0
2025-12-09 FRIEDEMAN JESSICA Officer — 15,000 $3.61 $54,158
2025-10-06 STRAWN JOHN R JR. Director — 22,365 $0.00 $0
2025-10-06 LAROVERE JOAN Director — 22,365 $0.00 $0
2025-10-02 SIMON ROBERTO Director — 22,365 $0.00 $0
2025-10-02 DITROLIO JOSEPH Director — 22,365 $0.00 $0
2025-10-02 MACRAE CALUM ARCHIBALD Director — 22,365 $0.00 $0
2025-09-10 ALVAREZ NICHOLAS P Officer — 75,000 $5.92 $443,760
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
194.06
+25.34%
154.82
+1.49%
152.55
+28.15%
119.03
Operating Revenue
194.06
+25.34%
154.82
+1.49%
152.55
+28.15%
119.03
Cost Of Revenue
27.71
+29.26%
21.44
+13.44%
18.90
+1.25%
18.67
Reconciled Cost Of Revenue
27.71
+29.26%
21.44
+13.44%
18.90
+1.25%
18.67
Gross Profit
166.34
+24.71%
133.38
-0.20%
133.65
+33.16%
100.37
Operating Expense
174.01
+13.15%
153.79
+3.81%
148.14
+5.77%
140.05
Research And Development
7.35
+7.13%
6.86
+13.14%
6.06
+104.04%
2.97
Selling General And Administration
144.01
+12.46%
128.05
-0.07%
128.15
+2.25%
125.33
Selling And Marketing Expense
86.07
+22.78%
70.10
-8.30%
76.45
-2.45%
78.37
General And Administrative Expense
57.94
-0.02%
57.95
+12.10%
51.69
+10.08%
46.96
Other Gand A
57.94
-0.02%
57.95
+12.10%
51.69
+10.08%
46.96
Other Operating Expenses
22.65
+20.00%
18.88
+35.52%
13.93
+18.54%
11.75
Total Expenses
201.72
+15.12%
175.23
+4.90%
167.04
+5.24%
158.72
Operating Income
-7.67
+62.41%
-20.40
-40.81%
-14.49
+63.49%
-39.69
Total Operating Income As Reported
-7.67
+62.41%
-20.40
-40.81%
-14.49
+66.65%
-43.45
EBITDA
-1.52
+89.33%
-14.21
-80.16%
-7.89
+78.03%
-35.92
Normalized EBITDA
-0.36
+97.46%
-14.21
-87.90%
-7.56
+76.52%
-32.22
Reconciled Depreciation
7.31
+18.08%
6.19
-6.22%
6.60
+75.06%
3.77
EBIT
-8.83
+56.74%
-20.40
-40.81%
-14.49
+63.49%
-39.69
Total Unusual Items
-1.16
0.00
+100.00%
-0.33
+91.21%
-3.70
Total Unusual Items Excluding Goodwill
-1.16
0.00
+100.00%
-0.33
+91.21%
-3.70
Special Income Charges
-1.16
0.00
+100.00%
-0.33
+91.21%
-3.70
Other Special Charges
1.16
—
0.33
+612.93%
-0.06
Impairment Of Capital Assets
—
—
0.00
-100.00%
8.86
Restructuring And Mergern Acquisition
—
—
0.00
+100.00%
-5.10
Net Income
14.35
+167.05%
-21.41
-3.95%
-20.60
+54.77%
-45.54
Pretax Income
-10.19
+54.88%
-22.58
-29.67%
-17.41
+61.01%
-44.66
Net Non Operating Interest Income Expense
-1.36
+37.44%
-2.18
+16.22%
-2.60
-103.50%
-1.28
Interest Expense Non Operating
1.36
-37.44%
2.18
—
—
Net Interest Income
-1.36
+37.44%
-2.18
+16.22%
-2.60
-103.50%
-1.28
Interest Expense
1.36
-37.44%
2.18
—
—
Other Income Expense
-1.16
—
-0.33
+91.21%
-3.70
Tax Provision
0.05
-92.35%
0.60
+39.72%
0.43
+18.66%
0.36
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.24
0.00
+100.00%
-0.07
+91.21%
-0.78
Net Income Including Noncontrolling Interests
15.62
+174.88%
-20.86
-16.94%
-17.84
+60.38%
-45.02
Net Income From Continuing Operation Net Minority Interest
-11.50
+51.54%
-23.72
-15.19%
-20.60
+54.77%
-45.54
Net Income From Continuing And Discontinued Operation
14.35
+167.05%
-21.41
-3.95%
-20.60
+54.77%
-45.54
Net Income Continuous Operations
-10.23
+55.85%
-23.18
-29.91%
-17.84
+60.38%
-45.02
Net Income Discontinuous Operations
25.85
+1016.60%
2.32
—
—
Minority Interests
-1.27
-130.60%
-0.55
+80.09%
-2.76
-435.71%
-0.51
Normalized Income
-10.58
+55.38%
-23.72
-16.64%
-20.34
+52.27%
-42.61
Net Income Common Stockholders
11.25
+145.88%
-24.52
-3.43%
-23.70
+51.27%
-48.64
Diluted EPS
0.25
+147.17%
-0.53
+24.29%
-0.70
+55.41%
-1.57
Basic EPS
0.25
+147.17%
-0.53
+24.29%
-0.70
+55.41%
-1.57
Basic Average Shares
45.13
+9.55%
41.20
+21.50%
33.91
+9.45%
30.98
Diluted Average Shares
45.13
+9.55%
41.20
+21.50%
33.91
+9.45%
30.98
Diluted NI Availto Com Stockholders
11.25
+145.88%
-24.52
-3.43%
-23.70
+51.27%
-48.64
Preferred Stock Dividends
3.11
+0.00%
3.11
+0.00%
3.11
+0.00%
3.11
Total Other Finance Cost
—
2.18
-15.97%
2.60
+103.50%
1.28
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
70.41
-7.47%
76.10
+30.12%
58.48
+127.85%
25.67
Current Assets
51.83
-1.03%
52.37
+22.92%
42.60
+276.65%
11.31
Cash Cash Equivalents And Short Term Investments
36.79
+12.66%
32.65
-1.49%
33.15
+737.26%
3.96
Cash And Cash Equivalents
36.79
+12.66%
32.65
-1.49%
33.15
+737.26%
3.96
Cash Financial
36.79
+12.66%
32.65
-1.49%
33.15
+737.26%
3.96
Receivables
9.31
-11.00%
10.46
+98.13%
5.28
+86.16%
2.83
Accounts Receivable
9.31
-11.00%
10.46
+98.13%
5.28
+86.16%
2.83
Gross Accounts Receivable
9.66
-12.20%
11.00
+89.50%
5.81
+59.06%
3.65
Allowance For Doubtful Accounts Receivable
-0.35
+35.23%
-0.55
-3.22%
-0.53
+35.21%
-0.81
Inventory
2.77
-0.85%
2.80
+1.36%
2.76
-25.47%
3.70
Raw Materials
0.85
-43.23%
1.51
+23.77%
1.22
-4.70%
1.28
Finished Goods
2.07
+33.28%
1.55
-18.13%
1.90
-26.61%
2.59
Prepaid Assets
0.32
+685.56%
0.04
-91.61%
0.49
+281.76%
0.13
Assets Held For Sale Current
0.00
-100.00%
3.42
—
—
Other Current Assets
2.65
-11.90%
3.00
+221.40%
0.93
+36.02%
0.69
Total Non Current Assets
18.58
-21.69%
23.73
+49.45%
15.88
+10.60%
14.35
Net PPE
7.71
+0.58%
7.67
+615.85%
1.07
-36.33%
1.68
Gross PPE
9.42
+10.69%
8.51
+694.48%
1.07
-36.33%
1.68
Accumulated Depreciation
-1.71
-102.76%
-0.84
—
—
Properties
—
0.00
0.00
0.00
Buildings And Improvements
—
6.40
+975.92%
0.59
-50.67%
1.21
Machinery Furniture Equipment
4.15
+81.98%
2.28
—
—
Other Properties
5.27
-15.42%
6.23
+481.46%
1.07
-36.33%
1.68
Goodwill And Other Intangible Assets
10.87
+16.11%
9.36
-36.78%
14.81
+16.83%
12.67
Other Intangible Assets
10.87
+16.11%
9.36
-36.78%
14.81
+16.83%
12.67
Other Non Current Assets
—
6.70
—
—
Total Liabilities Net Minority Interest
47.25
-43.51%
83.65
+58.09%
52.91
+60.49%
32.97
Current Liabilities
41.57
-38.32%
67.40
+93.78%
34.78
+10.86%
31.37
Payables And Accrued Expenses
27.71
+0.56%
27.55
+25.14%
22.02
+1.48%
21.70
Payables
16.39
+17.52%
13.95
-7.03%
15.00
-5.33%
15.85
Accounts Payable
14.15
+29.75%
10.90
-1.63%
11.08
+9.68%
10.11
Other Payable
—
—
0.64
-73.97%
2.46
Dividends Payable
0.78
+0.00%
0.78
+0.00%
0.78
+0.00%
0.78
Current Accrued Expenses
11.32
-16.84%
13.61
+93.93%
7.02
+19.93%
5.85
Pensionand Other Post Retirement Benefit Plans Current
2.41
-52.72%
5.11
+70.04%
3.00
+421.33%
0.58
Total Tax Payable
1.47
-35.28%
2.27
-9.34%
2.50
+0.00%
2.50
Current Debt And Capital Lease Obligation
0.64
-92.67%
8.76
+841.64%
0.93
-73.81%
3.55
Current Debt
—
8.44
+2477.69%
0.33
-88.29%
2.80
Other Current Borrowings
—
8.44
—
—
Current Capital Lease Obligation
0.64
+100.71%
0.32
-46.93%
0.60
-20.22%
0.76
Current Deferred Liabilities
10.81
-36.79%
17.10
+93.66%
8.83
+59.15%
5.55
Current Deferred Revenue
10.81
-36.79%
17.10
+93.66%
8.83
+59.15%
5.55
Other Current Liabilities
—
8.88
—
—
Total Non Current Liabilities Net Minority Interest
5.68
-65.04%
16.25
-10.38%
18.13
+1035.28%
1.60
Liabilities Heldfor Sale Non Current
0.00
-100.00%
0.09
—
—
Long Term Debt And Capital Lease Obligation
5.68
-64.85%
16.16
-10.21%
18.00
+3035.42%
0.57
Long Term Debt
—
9.89
-44.86%
17.93
—
Long Term Capital Lease Obligation
5.68
-9.52%
6.28
+8402.49%
0.07
-87.14%
0.57
Tradeand Other Payables Non Current
—
—
0.00
-100.00%
0.58
Other Non Current Liabilities
—
0.10
-23.81%
0.13
-70.42%
0.44
Stockholders Equity
23.16
+354.94%
-9.08
-359.12%
3.51
+151.32%
-6.83
Common Stock Equity
23.16
+354.93%
-9.08
-359.14%
3.51
+130.76%
-11.40
Capital Stock
0.47
+10.56%
0.42
+10.26%
0.38
-92.14%
4.88
Common Stock
0.47
+10.56%
0.42
+10.26%
0.38
+21.57%
0.32
Preferred Stock
0.00
+0.00%
0.00
+0.00%
0.00
-100.00%
4.57
Share Issued
46.76
+10.56%
42.29
+10.26%
38.36
+21.57%
31.55
Ordinary Shares Number
46.66
+10.59%
42.19
+10.29%
38.26
+21.64%
31.45
Treasury Shares Number
0.10
+0.00%
0.10
+0.00%
0.10
+0.00%
0.10
Additional Paid In Capital
251.46
+9.09%
230.51
+5.96%
217.55
+21.53%
179.02
Retained Earnings
-228.60
+4.69%
-239.85
-11.94%
-214.27
-12.44%
-190.56
Treasury Stock
0.16
+0.00%
0.16
+0.00%
0.16
+0.00%
0.16
Minority Interest
0.00
-100.00%
1.53
-25.80%
2.06
+533.35%
-0.48
Total Equity Gross Minority Interest
23.16
+406.54%
-7.55
-235.72%
5.57
+176.19%
-7.31
Total Capitalization
23.16
+2787.92%
0.80
-96.26%
21.43
+413.81%
-6.83
Working Capital
10.26
+168.25%
-15.03
-292.15%
7.82
+138.99%
-20.06
Invested Capital
23.16
+150.44%
9.25
-57.51%
21.76
+353.07%
-8.60
Total Debt
6.32
-74.63%
24.93
+31.67%
18.93
+358.69%
4.13
Capital Lease Obligations
6.32
-4.17%
6.60
+874.71%
0.68
-49.10%
1.33
Net Tangible Assets
12.29
+166.64%
-18.44
-63.21%
-11.30
+42.06%
-19.50
Tangible Book Value
12.29
+166.63%
-18.44
-63.21%
-11.30
+53.05%
-24.07
Current Notes Payable
—
0.00
-100.00%
0.33
-88.29%
2.80
Interest Payable
—
—
0.00
-100.00%
0.45
Inventories Adjustments Allowances
-0.15
+41.75%
-0.26
+25.97%
-0.36
-121.06%
-0.16
Preferred Shares Number
1.40
+0.00%
1.40
+0.00%
1.40
+0.00%
1.40
Preferred Stock Equity
0.00
+0.00%
0.00
+0.00%
0.00
-100.00%
4.57
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
8.28
-52.72%
17.51
+98.56%
8.82
+138.46%
-22.94
Cash Flow From Continuing Operating Activities
2.07
-85.57%
14.36
+62.85%
8.82
+138.46%
-22.94
Cash From Discontinued Operating Activities
6.21
+97.08%
3.15
—
—
Net Income From Continuing Operations
-10.23
+55.85%
-23.18
-29.91%
-17.84
+60.38%
-45.02
Depreciation Amortization Depletion
7.31
+18.08%
6.19
-6.22%
6.60
+75.06%
3.77
Depreciation
0.87
+85.80%
0.47
+128.40%
0.20
+25.99%
0.16
Amortization Cash Flow
6.44
+12.57%
5.72
-10.52%
6.40
+77.26%
3.61
Depreciation And Amortization
7.31
+18.08%
6.19
-6.22%
6.60
+75.06%
3.77
Amortization Of Intangibles
6.44
+12.57%
5.72
-10.52%
6.40
+77.26%
3.61
Other Non Cash Items
1.20
+9.80%
1.09
-39.51%
1.80
+151.94%
-3.46
Stock Based Compensation
10.50
-14.21%
12.23
-2.04%
12.49
-9.07%
13.73
Provisionand Write Offof Assets
—
—
0.00
-100.00%
0.34
Asset Impairment Charge
0.00
-100.00%
0.68
+25.66%
0.54
-94.00%
8.97
Deferred Tax
—
—
0.00
-100.00%
0.35
Deferred Income Tax
—
—
0.00
-100.00%
0.35
Operating Gains Losses
1.16
—
0.33
+612.93%
-0.06
Change In Working Capital
-7.85
-145.25%
17.35
+253.56%
4.91
+416.80%
-1.55
Change In Receivables
1.15
+125.64%
-4.49
-83.73%
-2.44
-11.38%
-2.19
Changes In Account Receivables
1.15
+125.64%
-4.49
-83.73%
-2.44
-11.38%
-2.19
Change In Inventory
0.02
+103.34%
-0.71
-275.75%
0.41
+118.59%
-2.18
Change In Prepaid Assets
-0.28
-162.79%
0.45
+224.12%
-0.36
-570.02%
0.08
Change In Payables And Accrued Expense
-2.54
-117.00%
14.93
+163.95%
5.66
+9699.05%
-0.06
Change In Accrued Expense
-5.78
-153.77%
10.76
+129.87%
4.68
+457.17%
-1.31
Change In Payable
3.24
-22.31%
4.18
+326.98%
0.98
-21.82%
1.25
Change In Account Payable
3.24
-22.31%
4.18
+326.98%
0.98
-21.82%
1.25
Change In Other Working Capital
-6.29
-164.01%
9.83
+263.70%
2.70
-14.48%
3.16
Change In Other Current Assets
0.36
+115.74%
-2.27
-817.37%
-0.25
-333.11%
0.11
Change In Other Current Liabilities
-0.28
+27.78%
-0.38
+52.84%
-0.81
-77.35%
-0.46
Investing Cash Flow
6.91
+159.88%
-11.54
-32.10%
-8.73
+37.20%
-13.91
Cash Flow From Continuing Investing Activities
-9.52
-16.05%
-8.20
+6.08%
-8.73
+37.20%
-13.91
Cash From Discontinued Investing Activities
16.43
+592.67%
-3.33
—
—
Net PPE Purchase And Sale
-1.87
-27.83%
-1.46
-617.99%
-0.20
+44.41%
-0.37
Purchase Of PPE
-1.87
-27.83%
-1.46
-617.99%
-0.20
+44.41%
-0.37
Capital Expenditure
-9.52
-16.05%
-8.20
+6.08%
-8.73
+32.27%
-12.89
Capital Expenditure Reported
-7.65
-13.49%
-6.74
+19.59%
-8.38
+1.71%
-8.53
Net Business Purchase And Sale
—
—
0.00
+100.00%
-1.01
Purchase Of Business
—
—
0.00
+100.00%
-1.01
Net Intangibles Purchase And Sale
—
-0.00
+97.45%
-0.15
+96.28%
-4.00
Purchase Of Intangibles
—
-0.00
+97.45%
-0.15
+96.28%
-4.00
Financing Cash Flow
-13.41
-225.52%
-4.12
-114.15%
29.10
+5609.43%
-0.53
Cash Flow From Continuing Financing Activities
-12.63
-281.27%
-3.31
-111.39%
29.10
+5609.43%
-0.53
Net Issuance Payments Of Debt
-18.72
-5614.25%
-0.33
-101.96%
16.67
+509.08%
2.74
Issuance Of Debt
—
0.00
-100.00%
21.81
+650.67%
2.91
Repayment Of Debt
-18.72
-5614.25%
-0.33
+93.63%
-5.14
-2947.43%
-0.17
Long Term Debt Issuance
—
0.00
-100.00%
19.47
0.00
Long Term Debt Payments
-18.72
-5614.25%
-0.33
—
0.00
Net Long Term Debt Issuance
-18.72
-5614.25%
-0.33
-101.68%
19.47
0.00
Short Term Debt Issuance
—
0.00
-100.00%
2.35
-19.21%
2.91
Short Term Debt Payments
—
-0.33
+93.63%
-5.14
-2947.43%
-0.17
Net Short Term Debt Issuance
—
-0.33
+88.28%
-2.79
-202.10%
2.74
Net Common Stock Issuance
8.72
0.00
-100.00%
16.20
0.00
Cash Dividends Paid
-3.11
+0.00%
-3.11
+0.00%
-3.11
+0.00%
-3.11
Proceeds From Stock Option Exercised
0.47
+291.40%
0.12
+27.31%
0.09
-26.69%
0.13
Net Other Financing Charges
—
-0.81
-5.64%
-0.76
-164.53%
-0.29
Changes In Cash
1.78
-4.13%
1.86
-93.63%
29.19
+178.11%
-37.37
Beginning Cash Position
35.00
+5.61%
33.15
+737.26%
3.96
-90.42%
41.33
End Cash Position
36.79
+5.09%
35.00
+5.61%
33.15
+737.26%
3.96
Free Cash Flow
-1.24
-113.30%
9.31
+10608.80%
0.09
+100.24%
-35.83
Interest Paid Supplemental Data
1.46
-42.21%
2.53
+17.67%
2.15
+1036.75%
0.19
Income Tax Paid Supplemental Data
0.59
+174.03%
0.21
—
—
Common Stock Issuance
8.72
0.00
-100.00%
16.20
0.00
Issuance Of Capital Stock
8.72
0.00
-100.00%
16.20
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Dividend Paid
-3.11
+0.00%
-3.11
+0.00%
-3.11
+0.00%
-3.11
Preferred Stock Issuance
—
—
—
0.00
Cash From Discontinued Financing Activities
-0.77
+3.91%
-0.81
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category